NSE - SMEListed
Sheel Biotech Limited

Sheel Biotech Limited

Company website
Sheel Biotech Limited — Issue: ₹54,00,000 cr, Fresh: ₹54,00,000 cr, OFS: ₹0 cr.
Total shares on offer: 2000. Apply from 30-09-2025 to 03-10-2025. Consider your investment horizon — IPOs can be volatile on listing day.
Start Date30-09-2025
End Date03-10-2025
Listing Date08-10-2025
Allotment Date06-10-2025
Current Price₹91
GMP₹15 (23.81%)
Lot Size2000 Shares
Subscription16.05 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹59 - ₹63
Pre Issue₹1,49,52,550
Post Issue₹2,03,52,550
Issue Size₹54,00,000
(aggregating up to 34.02 Cr)
Fresh Issue₹54,00,000
(aggregating up to 34.02 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Sheel Biotech Limited is currently around ₹15 (23.81%). This indicates an estimated listing price of approximately ₹74 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
21 Nov 2025, 09:03
₹63
₹15
₹78 (23.81%)
03 Nov 2025, 10:33
₹63
₹15
₹78 (23.81%)
07 Oct 2025, 12:59
₹63
₹15
₹78 (23.81%)
06 Oct 2025, 04:56
₹63
₹8
₹71 (12.70%)
05 Oct 2025, 15:48
₹63
₹2
₹65 (3.17%)
04 Oct 2025, 07:27
₹63
₹6
₹69 (9.52%)
03 Oct 2025, 13:07
₹63
₹6
₹69 (9.52%)
01 Oct 2025, 15:38
₹63
₹2
₹65 (3.17%)
30 Sep 2025, 09:51
₹63
₹0
₹63 (0.00%)
29 Sep 2025, 12:31
₹63
₹0
₹63 (0.00%)
26 Sep 2025, 07:56
₹63
₹0
₹63 (0.00%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Sheel Biotech Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIMar-25Mar-24Mar-23
EPS
7.21
7.22
3.5
ROE
13.59
15.38
8.23
ROCE
0
0
0
RONW
13.59
15.38
8.23
PRE IPO(PE)
8.96
0
0
POST IPO(PE)
44.07
0
0

Subscription Details (No. of Shares)

The below shows how many shares were subscribed by each investor category in the Sheel Biotech Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹6.46
127.54
19.74
FIIs
₹0
37.43
0.00
Others
₹0
90.1
0.00
RETAIL
₹11.37
108.74
9.56
HNIs 2+
₹1.63
23.66
14.52
HNIs 10+
₹3.25
104.55
32.17
Total
₹22.71
364.49
16.05

Application Wise Breakup (Approx. no of Apps)

CategoryReservedAppliedTimes
QIB
0
18
0.00
NIB
0
1,363
0.00
RETAIL
451
4,315
9.57
HNIs(10L +)
86
761
8.85
HNIs (2-10L)
43
602
14.00
Total
580
5,678
9.79
The IPO reservation for Sheel Biotech Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
Anchor
28.22%
15,24,000
QIB
19.00%
10,26,000
HNI
14.33%
7,74,000
RETAIL
33.41%
18,04,000
Market Maker
5.04%
2,72,000
TOTAL
100.00%
54,00,000

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
2
4,000
₹2,52,000
0
sHNI
3
6,000
₹3,78,000
0
bHNI
8
16,000
₹10,08,000
0
Below you can find the official contact details of Sheel Biotech Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 88511 - 8980
Address: 8 Balaji Estates , 2nd Floor, Block-C, Guru Ravidas Marg Kalkaji South Delhi, New Delhi, 110019

IPO Registrar

Name: Skyline Financial Services Private Limited
Phone: 02228511022
Sheel Biotech Limited IPO Details — GMP: ₹15 (23.81%) | Grey Market IPO